Mereo BioPharma Group plc (MREO) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $40.92M | -32.9% |
| 2024 | $60.97M | +20.6% |
| 2023 | $50.54M | -1.7% |
| 2022 | $51.40M | -44.2% |
| 2021 | $92.20M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $40.92M | -32.9% |
| 2024 | $60.97M | +20.6% |
| 2023 | $50.54M | -1.7% |
| 2022 | $51.40M | -44.2% |
| 2021 | $92.20M | — |